Cover Image
Market Research Report
Product code 
1086250

Pediatric Vaccines Market, by Vaccine Type, by Vaccine Form, by Application, By End User, and by Region - Global Forecast, 2022 - 2028

Published: | Coherent Market Insights | 190 Pages | Delivery time: 2-3 business days

Price

Back to Top
Pediatric Vaccines Market, by Vaccine Type, by Vaccine Form, by Application, By End User, and by Region - Global Forecast, 2022 - 2028
Published: May 24, 2022
Coherent Market Insights
Content info: 190 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Pediatric vaccines perform significant role in reduction of various childhood infectious disease such as measles, diphtheria, Poliomyelitis, and Haemophilus influenzae type b (Hib). Increasing Government of various economies, healthcare regulatory organizations, and private organizations are focused on reducing rate of pediatric disease, which is expected to propel demand for pediatric vaccine over the forecast period. For instance, in 2013, World Health Organization (WHO): Europe launched the flu Awareness Campaign initiative to spread awareness regarding flu among the European population.adoption of pediatric vaccines have significantly led to increase in global vaccination coverage. According to the World Health Organization (WHO), immunization helps to prevent around 2 to 3 million deaths annually. Moreover, vaccination is the most cost-effective and efficient heath investment, which is accessible to hard-to-reach locations and vulnerable populations. High prevalence of infectious disease, combined with increasing numbers of government initiatives for raising awareness regarding immunization and development of novel adjuvants and therapeutic vaccines are expected to drive growth of pediatric vaccines market during the forecast period.

Restraints of the Global Pediatric Vaccines Market

Low private sector involvement in low income countries countries such as Nigeria, Cambodia, and several others is hampering growth of the market, as these countries are majorly dependent on government vaccinations.

Key features of the study:

  • This report provides in-depth analysis of the global pediatric vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global pediatric vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi, Pancea Biotec, Zydua Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Pediatric Vaccines Market, By Vaccine Type:
  • Pneumonococcal Vaccine
  • DTP Vaccine
  • Rotavirus Vaccine
  • MMR Vaccine
  • Polio Vaccine
  • Influenza Vaccine
  • Hepatitis B Vaccine
  • Meningococcal Vaccine
  • Hib Vaccine
  • Varicella Vaccine
  • Global Pediatric Vaccines Market, By Technology:
  • Live or Attenuated Vaccine
  • Inactivated or Killed Vaccine
  • Toxoid Vaccine
  • Conjugate Vaccine
  • Subunit Vaccine
  • Recombinant Vaccine
  • Global Pediatric Vaccines Market, By Type:
  • Monovalent Vaccine
  • Multivalent Vaccine
  • Global Pediatric Vaccines Market, By Distribution Channel:
  • Government
  • Private
  • Global Pediatric Vaccines Market, By Geography:
  • North America

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country:

? U.S.

? Canada

  • Europe

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country:

? U.K.

? Germany

? Italy

? France

? Spain

? Russia

? Rest of Europe

  • Asia Pacific

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country:

? China

? India

? Japan

? ASEAN

? Australia

? South Korea

? Rest of Asia Pacific

  • Latin America

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country:

? Brazil

? Mexico

? Argentina

? Rest of Latin America

  • Middle East:

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country:

? GCC

? Israel

? Rest of Middle East

  • Africa

? By Vaccine Type

? Pneumococcal Vaccine

? DTP Vaccine

? Rotavirus Vaccine

? MMR Vaccine

? Polio Vaccine

? Influenza Vaccine

? Hepatitis B Vaccine

? Meningococcal Vaccine

? Hib Vaccine

? Varicella Vaccine

? By Technology:

? Live or Attenuated Vaccine

? Inactivated or Killed Vaccine

? Toxoid Vaccine

? Conjugate Vaccine

? Subunit Vaccine

? Recombinant Vaccine

? By Type

? Monovalent Vaccine

? Multivalent Vaccine

? By Distribution Channel

? Government

? Private

? By Country/Region:

? Central Africa

? South Africa

? North Africa

  • Company Profiles
  • GlaxoSmithKline Plc.*

? Company Overview

? Product Portfolio

? Financial Performance

? Key Strategies

? Recent Developments

  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Panacea Biotec
  • Zydus Cadila
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Indian Immunologicals Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1708

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Vaccine Type
    • Market Snippet By Vaccine Form
    • Market Snippet By Application
    • Market Snippet By End-User
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Market Trends
    • Epidemiology
    • Key Developments
    • Awareness Strategies
    • Merger and Acquisitions
    • Regulatory Scenario
    • New Product Approvals/Launch
    • PEST Analysis
    • Porter's Analysis

4. Global Pediatric Vaccines Market, By Vaccine Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Monovalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Multivalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

5. Global Pediatric Vaccines Market, By Vaccine Form, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Attenuated Live Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Inactivated Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Subunits
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Toxoids
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Recombinant
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Polysaccharides
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Conjugates
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

6. Global Pediatric Vaccines Market, By Application, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
  • Allergy
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

7. Global Pediatric Vaccines Market, By End-User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Pediatric Clinics
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Academic & Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

8. Global Pediatric Vaccines Market, By Regions, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Eli Lilly Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Aventis Pharma Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Indian Immunologicals Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Zydus Cadila
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Panacea Drugs Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sinovac Biotech Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact